Your browser doesn't support javascript.
loading
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.
Renner, Tyler M; Akache, Bassel; Stuible, Matthew; Rohani, Nazanin; Cepero-Donates, Yuneivy; Deschatelets, Lise; Dudani, Renu; Harrison, Blair A; Baardsnes, Jason; Koyuturk, Izel; Hill, Jennifer J; Hemraz, Usha D; Régnier, Sophie; Lenferink, Anne E G; Durocher, Yves; McCluskie, Michael J.
Affiliation
  • Renner TM; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
  • Akache B; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
  • Stuible M; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • Rohani N; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • Cepero-Donates Y; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • Deschatelets L; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
  • Dudani R; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
  • Harrison BA; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
  • Baardsnes J; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • Koyuturk I; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • Hill JJ; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
  • Hemraz UD; National Research Council Canada, Aquatic and Crop Resource Development, Montreal, QC, Canada.
  • Régnier S; National Research Council Canada, Aquatic and Crop Resource Development, Montreal, QC, Canada.
  • Lenferink AEG; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • Durocher Y; National Research Council Canada, Human Health Therapeutics, Montreal, QC, Canada.
  • McCluskie MJ; National Research Council Canada, Human Health Therapeutics, Ottawa, ON, Canada.
Front Immunol ; 14: 1182556, 2023.
Article in En | MEDLINE | ID: mdl-37122746

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Adjuvants, Vaccine Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Adjuvants, Vaccine Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Canada